2026-09-09
Betting the Umbilical Cord's "Young Cells" on Stroke — Yet Among 285 References, Not One Stroke Clinical Trial Is Explicitly Identified as Wharton's Jelly-Derived
We read a review that promotes the "young" mesenchymal stem cells harvested from the umbilical cord jelly thrown away at every birth, along with their secreted products, as the trump card of post-stroke regenerative medicine. There are no new data, and no literature search procedure is written down. And among its 285 references, there was not a single clinical trial that gave stroke patients material explicitly identified as Wharton's jelly-derived.
解説を読む →
